A prospective study of symptomatic bacteremia following platelet transfusion and of its management

scientific article published on November 1994

A prospective study of symptomatic bacteremia following platelet transfusion and of its management is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1537-2995.1994.341195065031.X
P698PubMed publication ID7974703

P2093author name stringKwong YL
Chan TK
Lee AC
Yuen KY
Lau YL
Wong S
Lie AK
Ng MH
Liang R
Chiu EK
P433issue11
P921main subjectplatelet transfusionQ23925170
P304page(s)950-954
P577publication date1994-11-01
P1433published inTransfusionQ15758500
P1476titleA prospective study of symptomatic bacteremia following platelet transfusion and of its management
P478volume34

Reverse relations

cites work (P2860)
Q43030574A prospective study to determine the frequency of bacterial contamination of platelets
Q34326677Association of Laribacter hongkongensis in community-acquired gastroenteritis with travel and eating fish: a multicentre case-control study.
Q53724518Bacterial complications of blood transfusions
Q33719334Bacterial contamination of blood components
Q34522392Bacterial contamination of blood products: factors, options, and insights
Q35807467Bacterial contamination of cellular blood components: risks, sources and control
Q33397311Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis
Q34451446Bacterial contamination of platelet concentrates: incidence, significance, and prevention
Q50131406Clinical significance of alimentary tract microbes in bone marrow transplant recipients
Q41484589Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates
Q53909708Compodock, a new device for sterile docking.
Q33769745Considerations in the selection of a platelet component: apheresis versus whole blood-derived
Q33579171Current methods for the preparation of platelet concentrates: laboratory and clinical aspects
Q33338131Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study
Q40638359Diagnostic difficulties of transfusion incidents due to bacterial contamination: report of two cases
Q28168715Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days
Q52545960Electrochemiluminescent detection of bacteria in blood components.
Q34464623Freeze-dried blood cells: therapeutic advance or laboratory curiosity?
Q34153169Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates.
Q46401345In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools
Q30328537Inactivation of infectious pathogens in labile blood components: meeting the challenge.
Q30431256Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates
Q77925242Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: current research perspectives
Q37208873Incidence of bacterial transmission and transfusion reactions by blood components
Q34022474Leucocyte depletion of the blood supply - how will patients benefit?
Q40592824Methicillin-resistant Staphylococcus aureus sepsis associated with the transfusion of contaminated platelets: a case report
Q33361167Optimizing platelet transfusion therapy
Q33332598Pharmacologic treatment options in patients with thrombocytopenia
Q43655377Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function
Q41461282Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria
Q54260245Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases.
Q33581221Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective
Q46866924Prevalence of bacterial contamination of standard platelet units: prospective study
Q54439376Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods.
Q43980864Quality assurance of bacterial incidents associated with blood transfusion
Q44921346Quantitative bacteriological evaluation of a method for skin disinfection in blood donors
Q37208865Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products
Q40834176Rapid screening method for detection of bacteria in platelet concentrates
Q44849799Reduction of platelet transfusion- associated sepsis by short-term bacterial culture
Q37209101Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components
Q35122220Risks associated with transfusion of cellular blood components in canada
Q33328995Risks, costs, and alternatives to platelet transfusions
Q32044829Transfusion incidents related to bacterial contamination: review of the literature and hemovigilance data. For the working group Bacterial incidents of French Blood Agency, scientific advice of Bacthem and the French hemovigilance network
Q35064110Transfusion medicine for the pediatrician
Q33370536Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study
Q35743767Transfusion-transmitted bacterial infection: risks, sources and interventions
Q82261297What Was in Those Platelets?
Q73577980[Blood transfusion and bacterial risk]
Q74086190[Blood transfusion and bacterial risk]
Q79789964[New container of sample: role in the reduction of bacterial contamination of standard platelet units]

Search more.